Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway

Table 3 Proportions (%) of patients receiving hypoglycaemic, anti-hypertensive and statin therapy.

*Treatment groups*	*All (n = 1653)*	*Norwegians (n = 1129)*	*South Asians (n = 322)*	*MENA* ^a *(n = 81)*	*East Asians (n = 54)*	*Others* ^b *(n = 67)*	P ^c
Diet alone	24.7	27.9	16.1	21.0	20.4	19.4	<0.001
Oral agents	56.1	54.8	57.8	61.7	61.1	58.2	0.19
Insulin and oral agents	9.5	7.5	16.1	7.4	5.6	16.4	0.001
Insulin alone	9.7	9.7	9.9	9.9	13.0	6.0	0.66
Anti-hypertensive therapy	61.1	69.4	43.2	34.6	44.4	53.7	<0.001
Statin therapy	39.0	42.8	35.7	24.7	22.2	22.4	<0.001

^a Patients from Middle East/North Africa.
^b Patients from other regions.
^c p-values. Chi-squared tests were applied to identify differences between ethnic groups receiving treatment.

ISSN: 1472-6963